We are live on ! Find out more
BDSX icon

Biodesix

41 hedge funds and large institutions have $21.4M invested in Biodesix in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.76% less ownership

Funds ownership: 15.73% → 14.98% (-0.76%)

2% less funds holding

Funds holding: 42 → 41 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

41% less capital inflows, than outflows

Capital inflows: $2.9M | Capital outflows: $4.96M

Holders
41
Holders Change
-1
Holders Change %
-2.38%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
21
Reduced
8
Closed
7
Calls
$68​K
Puts
–
Net Calls
+$68​K
Net Calls Change
+$66​K

BDSX Hedge Fund Activity: Q4 2021 in Review

41 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2021, worth a combined $21.4M — down 39% from $34.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BDSX and 6 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 21 added.

The largest buyer was Birchview Capital, adding an estimated $965K. The largest seller was Oracle Investment Management, exiting entirely with an estimated $1.49M sold.

  • 41 institutional investors held Biodesix (BDSX) as of Q4 2021, down from 42 in Q3 2021.
  • Funds reported $21.4M of Biodesix stock for Q4 2021, down 39% quarter-over-quarter.
  • 6 funds opened new Biodesix positions in Q4 2021 and 7 closed out, a net change of -1 holder.
  • The largest Biodesix buyer in Q4 2021 was Birchview Capital, an estimated $965K added.
  • The largest Biodesix seller in Q4 2021 was Oracle Investment Management, an estimated $1.49M sold.

Based on aggregated 13F filings for Q4 2021.